MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

PRECISION BIOSCIENCES INC (DTIL)

PRECISION BIOSCIENCES INC (DTIL)

|||

Cash Flow Overview

Free Cash flow
-$13,442K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Loss on change in fair value of ...
    • Accounts receivable
    • Share-based compensation
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Other liabilities and other curr...
    • Prepaid expenses
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-32,652
-18,441
20,133
-21,772
Depreciation and amortization
253
299
345
350
Share-based compensation
1,844
1,549
2,041
2,386
Impairment charges
-
-
36
-
(gain) loss on disposal of assets
1
4
-390
3
Issuance of common stock in exchange for services
-
-
259
-
Non-cash interest expense
-2
117
22
18
Amortization of right-of-use assets
350
341
333
324
Loss on changes in other fair value adjustments
-244
-2,951
-248
-3
Gain from equity method investment
0
0
-5,370
-591
Gain from disposal of business
-
-
855
-
Amortization of discount on note receivable
0
0
0
231
Loss (gain) on change in fair value of warrant liability
-
-
-
-1,179
Gain on change in fair value of warrant liability
-
-
11,129
-
Loss on change in fair value of warrant liability
-13,891
-7,107
-
-
Prepaid expenses
492
393
-2,747
-1,593
Marketable securities
-80
0
5,000
0
Convertible note receivable
-
-
0
0
Accounts receivable
-4,000
4,000
-4
4
Contract asset
0
0
0
0
Other assets and other current assets
-78
-42
-490
106
Accounts payable
-122
648
-1,050
220
Other liabilities and other current liabilities
-546
-1,796
2,151
528
Deferred revenue
0
0
-26,205
-9
Lease liabilities
-367
-357
-350
-337
Net cash used in operating activities
-13,442
-11,937
-11,250
-15,270
Purchases of property, equipment and software
0
18
19
0
Purchases of intangible assets
0
100
350
0
Proceeds from sale of equipment
1
4
44
17
Net cash used in investing activities
1
-114
-325
17
Proceeds from employee stock purchase plan
0
83
0
78
Proceeds from offering of common stock and warrants through underwritten offering, net of issuance costs
-
-
69,980
0
Proceeds from issuance of common stock through atm facility, net of issuance cost
0
0
7,536
1,581
Proceeds from issuance of common stock to collaboration partners and licensees
0
662
0
0
Repayment of revolving credit facility
-
-
0
0
Borrowings from term loan debt facility, net of issuance costs paid to lender
-
-
0
0
Net cash provided by financing activities
0
745
77,516
1,659
Net decrease in cash and cash equivalents
-13,441
-11,306
65,941
-13,594
Cash, cash equivalents, and restricted cash beginning of period
125,847
137,153
71,212
108,468
Cash, cash equivalents, and restricted cash end of period
112,406
-
-
-
Cash and cash equivalents
86,076
-
-
-
Restricted cash
26,330
-
-
-
Total of cash, cash equivalents and restricted cash
112,406
125,847
137,153
71,212
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from sale ofequipment$1K (-80.00%↓ Y/Y)Net cash used ininvesting activities$1K (100.31%↑ Y/Y)Net decrease in cashand cash...-$13,441K (43.20%↑ Y/Y)Canceled cashflow$1K Loss on change in fairvalue of warrant...-$13,891K Accounts receivable-$4,000K (-1646.72%↓ Y/Y)Share-based compensation$1,844K (-67.98%↓ Y/Y)Amortization of right-of-useassets$350K (-44.27%↓ Y/Y)Depreciation andamortization$253K (-67.27%↓ Y/Y)Loss on changes inother fair value...-$244K (89.90%↑ Y/Y)Marketable securities-$80K (82.76%↑ Y/Y)Other assets and othercurrent assets-$78K (-273.33%↓ Y/Y)Net cash used inoperating activities-$13,442K (65.82%↑ Y/Y)Canceled cashflow$20,740K Net loss-$32,652K (25.93%↑ Y/Y)Other liabilities andother current...-$546K (87.71%↑ Y/Y)Prepaid expenses$492K (-51.24%↓ Y/Y)Lease liabilities-$367K (42.02%↑ Y/Y)Accounts payable-$122K (-231.18%↓ Y/Y)Non-cash interestexpense-$2K (-101.37%↓ Y/Y)(gain) loss on disposalof assets$1K (102.94%↑ Y/Y)